TY - JOUR
T1 - Transfusion-related acute lung injury with anti-leukocyte antibodies identified both in patient's serum and in red cell concentrate
AU - Nishizawa, Masatoshi
AU - Hirayama, Fumiya
AU - Matsuyama, Nobuki
AU - Tada, Kohei
AU - Kaneko, Hitomi
AU - Watanabe, Mitsumasa
AU - Miura, Yasuo
AU - Tsudo, Mitsuru
PY - 2009/1
Y1 - 2009/1
N2 - We report a fatal case of transfusion-related acute lung injury (TRALI) with anti-leukocyte antibodies detected both in the patient's serum and in the causative red cell concentrate (RC-M.A.P). A 41-year-old Japanese woman diagnosed as having acute myeloid leukemia (AML, M2) developed TRALI caused by RC-M.A.P 15 days after the start of induction therapy for AML. Although we conducted intratracheal intubation, positive end-expiratory pressure ventilation, and steroid pulse therapy, she died 3 days after the onset of TRALI. We detected anti-human leukocyte antigen (HLA) class I antibody and anti-HLA class II antibody in the patient's serum and anti-neutrophil antibody in the RC-M.A.P, using the newly developed immunofluorescence tests with high specificity and low background interference. We assume that these anti-leukocyte antibodies were responsible for TRALI via an immune-mediated mechanism.
AB - We report a fatal case of transfusion-related acute lung injury (TRALI) with anti-leukocyte antibodies detected both in the patient's serum and in the causative red cell concentrate (RC-M.A.P). A 41-year-old Japanese woman diagnosed as having acute myeloid leukemia (AML, M2) developed TRALI caused by RC-M.A.P 15 days after the start of induction therapy for AML. Although we conducted intratracheal intubation, positive end-expiratory pressure ventilation, and steroid pulse therapy, she died 3 days after the onset of TRALI. We detected anti-human leukocyte antigen (HLA) class I antibody and anti-HLA class II antibody in the patient's serum and anti-neutrophil antibody in the RC-M.A.P, using the newly developed immunofluorescence tests with high specificity and low background interference. We assume that these anti-leukocyte antibodies were responsible for TRALI via an immune-mediated mechanism.
UR - http://www.scopus.com/inward/record.url?scp=64849116019&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=64849116019&partnerID=8YFLogxK
M3 - Article
C2 - 19225224
AN - SCOPUS:64849116019
VL - 50
SP - 16
EP - 22
JO - [Rinsho ketsueki] The Japanese journal of clinical hematology
JF - [Rinsho ketsueki] The Japanese journal of clinical hematology
SN - 0485-1439
IS - 1
ER -